# Peptides for 'Adrenal Fatigue' & Stress Burnout: Evidence vs Hype

> A clinical-editorial breakdown of the peptides marketed for 'adrenal fatigue,' stress and burnout — starting from the fact that 'adrenal fatigue' is not a recognized diagnosis, then grading Selank, DSIP and thymosin alpha-1 honestly against human, animal and absent evidence.

*Published 2026-06-30 · Updated 2026-07-01 · By Elena Soto, PharmD*

The short answer
"Adrenal fatigue" is **not a recognized medical diagnosis**, so **no peptide has any human evidence for it.**[1](https://peptidevox.com/#r1)[2](https://peptidevox.com/#r2) What can be graded honestly is the adjacent, legitimate territory — stress, anxiety, asthenia and HPA-axis physiology. On that target, **Selank** is the only candidate with controlled human data (Grade B for anxiety/asthenia); **DSIP**'s cortisol-lowering claim *failed* the one human test (Grade C, D for cortisol); and **thymosin alpha-1** is an immune peptide with no stress evidence at all (Grade D).[3](https://peptidevox.com/#r3)[5](https://peptidevox.com/#r5)[12](https://peptidevox.com/#r12)

This is informational and editorial content for research and educational purposes only. It is not medical advice, not a diagnosis, not a protocol to follow, and not a buying or sourcing guide. None of the peptides discussed here is an FDA-approved treatment for fatigue, stress, burnout or any "adrenal" condition. Dosing is reported strictly as it appears in the published literature, for completeness — not as a recommendation. Persistent fatigue can signal real, treatable disease; see a licensed clinician before considering any peptide.

## Is "adrenal fatigue" actually a real condition?

Start with the single most important fact: "adrenal fatigue" is not a recognized medical diagnosis. A systematic review of 58 studies (3,470 screened) published in *BMC Endocrine Disorders* concluded plainly that there is no substantiation that "adrenal fatigue" is an actual medical condition.[1](https://peptidevox.com/#r1) The Endocrine Society — the world's largest professional body of hormone specialists — states that no scientific proof exists to support adrenal fatigue as a true medical condition.[2](https://peptidevox.com/#r2) The construct holds that chronic stress "exhausts" the adrenal glands until they under-produce cortisol; but the systematic review found no consistent cortisol signature distinguishing supposed sufferers from healthy controls, and noted that the popular diagnostic tools — the cortisol awakening response and diurnal cortisol curve — track sleep quality rather than adrenal function, while the gold-standard insulin tolerance test was used in zero of the reviewed studies.[1](https://peptidevox.com/#r1)

This matters for how to read every peptide claim that follows. There is no peptide with any human evidence for "adrenal fatigue," because the condition itself has no validated definition or endpoint to test against. What *can* be evaluated honestly is the adjacent, legitimate territory: stress, anxiety, asthenia (a clinical term for pathological fatigue and weakness), and HPA-axis (hypothalamic-pituitary-adrenal) physiology. Chronic stress genuinely dysregulates the HPA axis — impaired glucocorticoid feedback, altered cortisol rhythm, and a pro-inflammatory shift are well documented and linked to anxiety, depression and ME/CFS.[7](https://peptidevox.com/#r7) From a functional, root-cause view, the symptom cluster blamed on "adrenal fatigue" is real, but the cause is almost never the adrenals — the Endocrine Society lists genuine culprits including true adrenal insufficiency, depression and obstructive sleep apnea.[2](https://peptidevox.com/#r2) You can read the full systematic review on [PubMed Central](https://pmc.ncbi.nlm.nih.gov/articles/PMC4997656/).

## Which peptides are marketed for stress and burnout, and what is the real evidence?

Three peptides dominate the "adrenal/energy" lists. Ranked by genuine evidence for the legitimate target, they separate cleanly into one human-evidenced candidate, one preclinical case where the human test failed, and one that is simply off-topic.

  Peptides marketed for "adrenal fatigue" / stress — evidence at a glance

    PeptideBest evidence for stress/anxietyGrade

    SelankRandomized comparative human trial (n=62) in GAD/neurasthenia; fMRI amygdala-connectivity change (n=52)B (human, for anxiety/asthenia)
    DSIP (Emideltide)Rodent corticosterone blunting; controlled human test found NO ACTH/cortisol reductionC overall; D for cortisol claim
    Thymosin alpha-1None — immune peptide with no stress/HPA/fatigue dataD (unstudied for indication)

**Selank** is a synthetic heptapeptide derivative of the endogenous tetrapeptide tuftsin, approved in Russia and Ukraine as a prescription intranasal anxiety spray but not FDA-approved. It is the only candidate with controlled human trials: in a randomized comparative trial, 62 patients with GAD and neurasthenia received either Selank or the benzodiazepine medazepam over roughly 14 days, with comparable anxiolytic efficacy on the Hamilton, Zung and CGI scales — but Selank additionally showed an antiasthenic (anti-fatigue) effect without sedation, cognitive impairment or dependence.[3](https://peptidevox.com/#r3) A resting-state fMRI study in 52 healthy adults found Selank altered right-amygdala functional connectivity versus placebo, corroborating a real central action.[4](https://peptidevox.com/#r4) That earns Grade B for anxiety/asthenia — genuine human evidence, but small, single-region (Russian) and unreplicated by any Western RCT, and never studied for "adrenal fatigue," cortisol, or burnout.[8](https://peptidevox.com/#r8)

**DSIP** (delta sleep-inducing peptide, now nominated as "Emideltide") is the cautionary case. In rodent stress models it blunted stress-induced corticosterone, reduced stress ulcers and normalized disrupted hormone rhythms — the entire basis for the "DSIP lowers cortisol" marketing.[6](https://peptidevox.com/#r6) But the decisive human test contradicts it: in healthy young men, intravenous DSIP versus placebo around CRH injections produced almost identical ACTH and cortisol responses, and the authors concluded the data do not support an inhibitory role of DSIP on ACTH and cortisol secretion in man.[5](https://peptidevox.com/#r5) Grade C overall (preclinical), dropping to D for the specific human cortisol claim. **Thymosin alpha-1** is an immune-modulating peptide with no human or animal evidence for stress, the HPA axis or cortisol; its research base is immunological, not neuroendocrine, and its appearance on "adrenal/energy" lists is category drift from immune-optimization marketing.[12](https://peptidevox.com/#r12)[7](https://peptidevox.com/#r7) Grade D — unproven because unstudied.

Proven vs hyped
Proven in humans: only Selank, and only for diagnosed anxiety/asthenia (not "adrenal fatigue"). Hyped: the idea that any peptide "lowers cortisol" or "fixes your stress hormones" in people — the one controlled human test of the leading cortisol candidate (DSIP) was negative.[5](https://peptidevox.com/#r5) Extrapolating "comparable to a benzodiazepine for GAD" into "fixes your work burnout" is unsupported.[3](https://peptidevox.com/#r3)

## What does the evidence NOT support?

Several specific claims circulate that the literature actively contradicts or fails to support. First, that "adrenal fatigue" exists as a treatable condition — it does not, per the 58-study systematic review and the Endocrine Society, and if adrenals genuinely *are* failing (true adrenal insufficiency), that is a medical emergency requiring real treatment, not a research peptide.[1](https://peptidevox.com/#r1)[2](https://peptidevox.com/#r2) Second, that any peptide "lowers cortisol" in humans — the one controlled human test of the leading candidate (DSIP) was negative, and animal corticosterone effects do not transfer automatically.[5](https://peptidevox.com/#r5) Third, that Selank is a proven "burnout" or "energy" cure — its real human data are for diagnosed anxiety, from small Russian trials, not for burnout in healthy stressed adults.[3](https://peptidevox.com/#r3)[8](https://peptidevox.com/#r8) Fourth, that thymosin alpha-1 supports energy, stress or the adrenals — no such evidence exists; it is an immune peptide.[12](https://peptidevox.com/#r12) Finally, that salivary cortisol-curve or "adrenal stress index" testing diagnoses anything actionable here — those assays largely reflect sleep, not adrenal capacity, and are not endorsed by endocrinology.[1](https://peptidevox.com/#r1)

## What are the safety, legal and sport-doping considerations?

The biggest harm is diagnostic: labeling fatigue as "adrenal fatigue" can delay diagnosis of real disease, and the Endocrine Society warns that taking unneeded adrenal hormone supplements can suppress the adrenal glands and precipitate a life-threatening adrenal crisis on withdrawal.[2](https://peptidevox.com/#r2) Peptide-specifically: Selank was well tolerated in short Russian trials with no sedation or dependence, but has no SSRI/SNRI/MAOI interaction data and no long-term human safety record; DSIP has only small, short human studies; and the FDA has flagged compounded thymosin alpha-1 for immunogenicity and impurity concerns.[3](https://peptidevox.com/#r3)[6](https://peptidevox.com/#r6)[9](https://peptidevox.com/#r9)

On U.S. legal status, none of these is FDA-approved. In September 2023 the FDA moved roughly 19 popular peptides (including thymosin alpha-1) into 503A Category 2, effectively barring compounding; after litigation the FDA agreed to public PCAC review, and per the April 16, 2026 notice, PCAC-bound peptides are being removed from Category 2 ahead of review meetings on July 23–24, 2026 — which does *not* make compounding automatically legal.[9](https://peptidevox.com/#r9)[10](https://peptidevox.com/#r10) DSIP (Emideltide) is on the July 2026 review list; Selank and thymosin alpha-1 are not.[9](https://peptidevox.com/#r9) In sport, none of the three is explicitly named on the 2026 Prohibited List, but because none is approved by a major regulator for human therapeutic use, all three plausibly fall under WADA's S0 catch-all, which prohibits unapproved substances at all times — athletes and military personnel should treat them as prohibited and verify with their governing body.[11](https://peptidevox.com/#r11)

**Bottom line.** At best, one of these peptides (Selank) has plausible, modestly evidenced stress-resilience and anti-fatigue activity in anxiety populations. None addresses a thing called "adrenal fatigue," because there is no such validated thing to address — and the most valuable step for persistent exhaustion is a real clinical evaluation, not a research-chemical vial. Regulatory facts here are current as of June 2026; the July 23–24, 2026 PCAC outcomes were pending at the time of writing and should be re-verified afterward.

---
Source: https://peptidevox.com/energy-cognition-mood/peptides-for-adrenal-fatigue
Index: https://peptidevox.com/llms.txt · Full text: https://peptidevox.com/llms-full.txt